sb 203580 has been researched along with 2,4-dichloro-1-nitrobenzene in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (2,4-dichloro-1-nitrobenzene) | Trials (2,4-dichloro-1-nitrobenzene) | Recent Studies (post-2010) (2,4-dichloro-1-nitrobenzene) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 17 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, CB; Gonçalo, M; Lopes, MC; Matos, TJ | 1 |
1 other study(ies) available for sb 203580 and 2,4-dichloro-1-nitrobenzene
| Article | Year |
|---|---|
DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells.
Topics: Active Transport, Cell Nucleus; Animals; Blotting, Western; CD40 Antigens; Cell Line; Cells, Cultured; Dendritic Cells; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Humans; Imidazoles; Immunohistochemistry; Kinetics; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Pyridines; Signal Transduction; Skin; Time Factors; Up-Regulation | 2005 |